June 12 – 17, 2022
COVID-19 has spurred the deployment of large sums of capital and major multilateral involvement in building vaccine manufacturing capacity in LMICs; however, manufacturing facilities will not be functional or sustainable without a skilled workforce to operate them. The Bill & Melinda Gates Foundation has developed a three-pronged approach to (1) Understand manufacturer needs; (2) Train via innovative and accessible materials; and (3) Build a sustainable ecosystem through linked initiatives.
Please click Download on the upper right corner to see the full abstract.
Please click Additional File below for the presentation.
Julia Kuhn, "Vaccine manufacturing capacity expansion – An approach to meet global needs based on Covid-19 learnings" in "Vaccine Technology VIII", Tarit Mukhopadhyay, Merck Research Laboratories, USA; Charles Lutsch, Sanofi Pasteur, France; Linda Hwee-Lin Lua, University of Queensland, Australia; Francesc Godia, Universitat Autònoma de Barcelona, Spain Eds, ECI Symposium Series, (2022). https://dc.engconfintl.org/vaccine_viii/94